[1] |
LoVerde PT. Schistosomiasis[J]. Adv Exp Med Biol, 2019, 1154: 45-70.
doi: 10.1007/978-3-030-18616-6_3
pmid: 31297759
|
[2] |
Zhang LJ,, Xu ZM,, Yang F, et al. Endemic status of schistosomiasis in People’s Republic of China in 2020[J]. Chin J Schisto Control, 2021, 33(3): 225-233. (in Chinese)
|
|
( 张利娟,, 徐志敏,, 杨帆, 等. 2020年全国血吸虫病疫情通报[J]. 中国血吸虫病防治杂志, 2021, 33(3): 225-233.)
|
[3] |
Zhao J,, Chen Y,, Yu YR, et al. STAT3 promotes schistosome-induced liver injury by inflammation, oxidative stress, proliferation, and apoptosis signal pathway[J]. Infect Immun, 2021, 89(3): e00309-320.
|
[4] |
Kong H,, He J,, Huang J, et al. Endothelin receptors promote schistosomiasis induced hepatic fibrosis via splenic B cells[J]. PLoS Pathog, 2020, 16(10): e1008947.
|
[5] |
Zhou HH,, Lv NY,, Tong SJ, et al. Resveratrol regulates M1/M2 polarization of mice infected with Schistosoma japonicum through mitochondria[J]. Chin pharmacol Bull, 2021, 37(1):98-106. (in Chinese)
|
|
( 周慧慧,, 吕年银,, 佟书娟, 等. 白藜芦醇通过线粒体调控血吸虫感染小鼠M1/M2极化[J]. 中国药理学通报, 2021, 37(1): 98-106.)
|
[6] |
Zheng B,, Zhang JQ,, Chen H, et al. T lymphocyte mediated liver immunopathology of schistosomiasis[J]. Front Immunol, 2020, 11: 61.
doi: 10.3389/fimmu.2020.00061
pmid: 32132991
|
[7] |
Dorhoi A,, Glaría E,, Garcia-Tellez T, et al. MDSCs in infectious diseases: regulation roles, and readjustment[J]. Cancer Immunol Immun, 2019, 68(4): 673-685.
doi: 10.1007/s00262-018-2277-y
|
[8] |
Yang ZZ,, Guo JC,, Weng LL, et al. Myeloid-derived suppressor cells-new and exciting players in lung cancer[J]. J Hematol Oncol, 2020, 13(1): 10.
doi: 10.1186/s13045-020-0843-1
|
[9] |
Yin K,, Xia XL,, Rui K, et al. Myeloid-derived suppressor cells: a new and pivotal player in colorectal cancer progression[J]. Front Oncol, 2020, 10: 610104.
doi: 10.3389/fonc.2020.610104
|
[10] |
Veglia F,, Perego M,, Gabrilovich D. Myeloid-derived suppressor cells coming of age[J]. Nat Immunol, 2018, 19(2): 108-119.
doi: 10.1038/s41590-017-0022-x
|
[11] |
Yang SH,, Kim J,, Lee MJ, et al. Abnormalities of plasma cytokines and spleen in senile APP/PS1/Tau transgenic mouse model[J]. Sci Rep, 2015, 5: 15703.
doi: 10.1038/srep15703
|
[12] |
Aiello I,, Finkielstein CV,, Paladino N, et al. Circadian disruption promotes tumor-immune micro environment remodeling favoring tumor cell proliferation[J]. Sci Adv, 2020, 6(42): eaaz4530.
|
[13] |
Liu D,, Wu J,, Cyster JG, et al. Requirements for cDC2 positioning in blood-exposed regions of the neonatal and adult spleen[J]. J Exp Med, 2020, 217(11): e20192300.
|
[14] |
Lewis SM,, Williams A,, Eisenbarth SC. Structure and function of the immune system in the spleen[J]. Sci Immunol, 2019, 4(33): eaau6085.
|
[15] |
Wang YJ,, Shen YJ,, Xu YX, et al. Observation on destroyed architecture of splenic lymphoid follicles in mice infected with Schistosoma japonicum by immunohistochemistry[J]. Chin J Schisto Control, 2017, 29(4): 468-470. (in Chinese)
|
|
( 王燕娟,, 沈玉娟,, 徐馀信, 等. 免疫组化法观察日本血吸虫感染破坏小鼠脾脏淋巴滤泡结构[J]. 中国血吸虫病防治杂志, 2017, 29(4): 468-470.)
|
[16] |
Tayukcuoglu E,, Horzum U,, Esendagli G, et al. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer[J]. Eur J Immunol, 2020, 50(12): 2067-2074.
doi: 10.1002/eji.202048666
|
[17] |
Corzo CA,, Cotter MJ,, Cheng PY, et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells[J]. J Immunol, 2009, 182(9): 5693-5701.
doi: 10.4049/jimmunol.0900092
|
[18] |
Weber R,, Groth C,, Lasser S, et al. IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy[J]. Cell Immunol, 2021, 359: 104254.
|
[19] |
Wang S,, Song R,, Ma J, et al. S100A8/A9 in inflammation[J]. Front Immunol, 2018, 9: 1298.
doi: 10.3389/fimmu.2018.01298
|
[20] |
Ohl K,, Tenbrock K. Reactive oxygen species as regulators of MDSC-mediated immune suppression[J]. Front Immunol, 2018, 9: 2499.
doi: 10.3389/fimmu.2018.02499
|
[21] |
Voronov E,, Dotan S,, Apte RN. IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice[J]. Int Immunol, 2010, 22(4): 245-257.
doi: 10.1093/intimm/dxq006
pmid: 20181656
|
[22] |
Van Ginderachter JA, Beschin A,, Raes G, et al. Myeloid-derived suppressor cells in parasitic infections[J]. Eur J Immunol, 2010, 40(11): 2976-2985.
doi: 10.1002/eji.201040911
pmid: 21061431
|
[23] |
Yang Q,, Qiu H,, Huang J, et al. A Schistosoma japonicum infection promotes the expansion of myeloid-derived suppressor cells by activating the JAK/STAT3 pathway[J]. J Immunol, 2017, 198(12): 4716-4727.
doi: 10.4049/jimmunol.1601860
|
[24] |
Gao YQ,, Li L,, Hu L, et al. Immuno-supressive function of myeloid derived suppressor cells to T cells in BALB/c mice infected with Schistosoma japonicum[J]. Chin J Immunol, 2019, 35(3): 269-273. (in Chinese)
|
|
( 高勇强,, 黎丽,, 胡丽, 等. 日本血吸虫感染小鼠的髓源抑制细胞对T细胞的免疫抑制[J]. 中国免疫学杂志, 2019, 35(3): 269-273.)
|
[25] |
Rasta JL,, Green WR. Myeloid-derived suppressor cells in murine AIDS inhibit B-cell responses in part via soluble mediators including reactive oxygen and nitrogen species, and TGF-β[J]. Virology, 2016, 499: 9-22.
doi: 10.1016/j.virol.2016.08.031
|
[26] |
Schwacha MG,, Scroggins SR,, Cap AP, et al. Bum injury is associated with an infiltration of the wound site with myeloid-derived suppressor cells[J]. Cell Immunol, 2019, 338: 21-26.
doi: S0008-8749(18)30555-0
pmid: 30902343
|